pyruvaldehyde has been researched along with Bone Diseases, Metabolic in 1 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, K | 1 |
| Kitazawa, R | 1 |
| Kondo, T | 1 |
| Mori, M | 1 |
| Hamada, Y | 1 |
| Nishida, M | 1 |
| Minami, Y | 1 |
| Haraguchi, R | 1 |
| Takahashi, Y | 1 |
| Kitazawa, S | 1 |
1 other study available for pyruvaldehyde and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Diabetic osteopenia by decreased β-catenin signaling is partly induced by epigenetic derepression of sFRP-4 gene.
Topics: Animals; beta Catenin; Bone Diseases, Metabolic; Cell Line; Diabetes Mellitus; DNA Methylation; Down | 2014 |